These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2757653)

  • 1. Reduction of doxorubicin toxicity by methylene blue in cultured rat myocardial cells.
    Anderson RJ; Babson JR
    Biochem Pharmacol; 1989 Aug; 38(15):2568-72. PubMed ID: 2757653
    [No Abstract]   [Full Text] [Related]  

  • 2. Modifying intracellular redox balance: an approach to improving therapeutic index.
    Hrushesky WJ; Olshefski R; Wood P; Meshnick S; Eaton JW
    Lancet; 1985 Mar; 1(8428):565-7. PubMed ID: 2857911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates.
    Konorev EA; Kennedy MC; Kalyanaraman B
    Arch Biochem Biophys; 1999 Aug; 368(2):421-8. PubMed ID: 10441396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats.
    Mostafa AM; Nagi MN; Al Rikabi AC; Al-Shabanah OA; El-Kashef HA
    Res Commun Mol Pathol Pharmacol; 1999; 106(3):193-202. PubMed ID: 11485049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of doxorubicin-induced cardiotoxicity in mice by taurine.
    Hamaguchi T; Azuma J; Awata N; Ohta H; Takihara K; Harada H; Kishimoto S; Sperelakis N
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):21-30. PubMed ID: 3353577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium protection against anthracycline toxicity in vitro.
    Zdanowicz MM; Barletta MA
    Magnes Res; 1991 Jun; 4(2):105-7. PubMed ID: 1911091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
    Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of adriamycin and daunorubicin myocardial toxicity by adenosine.
    Newman RA; Hacker MP; Krakoff IH
    Cancer Res; 1981 Sep; 41(9 Pt 1):3483-8. PubMed ID: 7260911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels.
    Wang GW; Kang YJ
    J Pharmacol Exp Ther; 1999 Mar; 288(3):938-44. PubMed ID: 10027829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-cerebral and metabolic effects of methylene blue in hypertonic sodium lactate during experimental cardiopulmonary resuscitation.
    Miclescu A; Basu S; Wiklund L
    Resuscitation; 2007 Oct; 75(1):88-97. PubMed ID: 17482336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alpha-tocopherol on doxorubicin-induced changes in rat heart lysosomal enzymes.
    Geetha A
    Indian J Exp Biol; 1993 Mar; 31(3):288-90. PubMed ID: 8500846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
    Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute cardiotoxicity of adriamycin in the rat: biochemical and ultrastructural investigations.
    Olson HM; Capen CC
    Lab Invest; 1977 Oct; 37(4):386-94. PubMed ID: 909284
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture.
    Hershko C; Link G; Tzahor M; Kaltwasser JP; Athias P; Grynberg A; Pinson A
    J Lab Clin Med; 1993 Sep; 122(3):245-51. PubMed ID: 8409700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice.
    Lin MC; Yin MC
    Cardiovasc Toxicol; 2013 Sep; 13(3):185-93. PubMed ID: 23322372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that lipid peroxidation by doxorubicin does not initiate the beat inhibition of cultured mouse myocardial cells.
    Takahashi K; Mayumi T; Kishi T
    Chem Pharm Bull (Tokyo); 1987 Nov; 35(11):4626-31. PubMed ID: 3442896
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of vitamin E against adriamycin-induced toxicity in rabbits.
    Wang YM; Madanat FF; Kimball JC; Gleiser CA; Ali MK; Kaufman MW; van Eys J
    Cancer Res; 1980 Apr; 40(4):1022-7. PubMed ID: 7357532
    [No Abstract]   [Full Text] [Related]  

  • 18. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
    Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
    Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin concentrations in plasma and myocardium and their respective roles in cardiotoxicity.
    Timour Q; Nony P; Lang J; Lakhal M; Trillet V; Faucon G
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):559-60. PubMed ID: 3154684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
    Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
    Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.